Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Allogene Therapeutics Inc (NASDAQ: ALLO) closed the day trading at $2.27 down -7.72% from the previous closing price of $2.46. In other words, the price has decreased by -$7.72 from its previous closing price. On the day, 3.08 million shares were traded. ALLO stock price reached its highest trading level at $2.52 during the session, while it also had its lowest trading level at $2.26.
Ratios:
For a better understanding of ALLO, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.35 and its Current Ratio is at 9.35. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.18.
On May 31, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $11.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 21 ’24 when Parker Geoffrey M. bought 36,404 shares for $2.84 per share.
Douglas Earl Martin bought 28,310 shares of ALLO for $78,844 on Aug 21 ’24. On Jun 18 ’24, another insider, MESSEMER DEBORAH M., who serves as the Director of the company, sold 18,641 shares for $2.28 each. As a result, the insider received 42,488 and left with 166,765 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALLO now has a Market Capitalization of 475955424 and an Enterprise Value of 276915648. For the stock, the TTM Price-to-Sale (P/S) ratio is 10979.97 while its Price-to-Book (P/B) ratio in mrq is 1.03. Its current Enterprise Value per Revenue stands at 6439.899 whereas that against EBITDA is -1.086.
Stock Price History:
Over the past 52 weeks, ALLO has reached a high of $5.78, while it has fallen to a 52-week low of $2.01. The 50-Day Moving Average of the stock is -17.47%, while the 200-Day Moving Average is calculated to be -28.17%.
Shares Statistics:
Over the past 3-months, ALLO traded about 2.02M shares per day on average, while over the past 10 days, ALLO traded about 2785950 shares per day. A total of 167.13M shares are outstanding, with a floating share count of 142.43M. Insiders hold about 33.91% of the company’s shares, while institutions hold 68.24% stake in the company. Shares short for ALLO as of 1730332800 were 37040821 with a Short Ratio of 18.32, compared to 1727654400 on 38512665. Therefore, it implies a Short% of Shares Outstanding of 37040821 and a Short% of Float of 24.870001.
